Plans, banks, governments and other healthcare organizations spent part of 2004 testing the waters around health savings accounts (HSAs) to determine their real value in 2005 and coming years. Several consumer surveys offered differing views on HSA popularity.
NATIONAL REPORTS - Plans, banks, governments and other healthcare organizations spent part of 2004 testing the waters around health savings accounts (HSAs) to determine their real value in 2005 and coming years. Several consumer surveys offered differing views on HSA popularity.
America's Health Insurance Plans (AHIP) reported that HSAs were catching on at a substantial rate with almost 440,000 people buying in through September 2004. A Watson Wyatt survey found that 71% of U.S. workers aren't familiar with the HSA concept.
VISA also recently commissioned a study-its interest would be in promoting its debit cards for use with HSAs-and found that 36% of consumers are aware of the HSA concept.
Ideally, HSAs would be attractive to small employers, the self-employed and the uninsured, although, with their long-term view, many argue they're a fit across the board. President Bush has pledged to make HSAs an option for federal employees this year.
"The vast majority of these HSA-eligible products are built upon some variant of a network-based platform, most often a PPO or an HMO," Ignagni says. "These facts clearly demonstrate that network-based HSAs are an attractive option to many consumers, especially those in the individual and small employer market, including many previously uninsured Americans."
According to Joe Martingale, Watson Wyatt's national healthcare strategy leader, it's not surprising that most Americans haven't heard of HSAs, but they are likely to gain momentum this year.
"Healthcare providers may be concerned about payment from consumers spending their own money, but many will have access to the accounts-sometimes through debit cards-to [receive payment] for care. In the long run, it will be in everyone's interest if consumers are more in control of their own health and the healthcare they use. After all, it's that kind of change that will lead to a more efficient healthcare marketplace."
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen
Mental Health Comorbidities Affect Uptravi Prescribing for PAH
October 23rd 2024New real-world data suggest that physicians are cautious about prescribing the prostacyclin-receptor agonist Uptravi (selexipag) to pulmonary arterial hypertension (PAH) patients with mental health conditions when evidence suggests that it is best to take a proactive approach to treating PAH.
Read More